Trial Outcomes & Findings for Hemodynamic Effects of Blood Flow Variation in Continuous Renal Replacement Therapy (NCT NCT03078504)
NCT ID: NCT03078504
Last Updated: 2020-03-30
Results Overview
Change in mean arterial pressure from period 1 to period 2
Recruitment status
TERMINATED
Study phase
NA
Target enrollment
6 participants
Primary outcome timeframe
10 minutes
Results posted on
2020-03-30
Participant Flow
Participant milestones
| Measure |
Experimental Arm
The patients will have the blood flow rate adjusted on CRRT gradually increased to assess the effect on hemodynamics
continuous renal replacement therapy using System One (TM) setup (Nxstage): Participants who have been prescribed continuous renal replacement therapy will have hemodynamic parameters measured at various blood flow rates
|
|---|---|
|
Overall Study
STARTED
|
6
|
|
Overall Study
COMPLETED
|
6
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Experimental Arm
n=6 Participants
The patients will have the blood flow rate adjusted on CRRT gradually increased to assess the effect on hemodynamics
continuous renal replacement therapy using System One (TM) setup (Nxstage): Participants who have been prescribed continuous renal replacement therapy will have hemodynamic parameters measured at various blood flow rates
|
|---|---|
|
Age, Continuous
|
67 years
STANDARD_DEVIATION 7 • n=6 Participants
|
|
Sex: Female, Male
Female
|
4 Participants
n=6 Participants
|
|
Sex: Female, Male
Male
|
2 Participants
n=6 Participants
|
|
Region of Enrollment
United States
|
6 participants
n=6 Participants
|
|
mean arterial pressure
|
79 mmHg
STANDARD_DEVIATION 12 • n=6 Participants
|
PRIMARY outcome
Timeframe: 10 minutesChange in mean arterial pressure from period 1 to period 2
Outcome measures
| Measure |
Experimental Arm
n=6 Participants
The patients will have the blood flow rate adjusted on CRRT gradually increased to assess the effect on hemodynamics
continuous renal replacement therapy using System One (TM) setup (Nxstage): Participants who have been prescribed continuous renal replacement therapy will have hemodynamic parameters measured at various blood flow rates
|
|---|---|
|
Blood Pressure Change
|
-0.2 mmHg
Standard Deviation 2
|
Adverse Events
Experimental Arm
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place